Aurobindo Pharma gets final USFDA nod for osteoporosis drug

Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More